On ECHEMI
Home > Drugs > Yantai Dongcheng Beifang Pharmaceutical Co., Ltd.
Yantai Dongcheng Beifang Pharmaceutical Co., Ltd.
  • Founded in:

    1993-02-26
  • Country:

    China China
  • Address:

    No. 22, Tianjin North Road, Economic and Technological Development Zone, Yantai City, Shandong Province
  • Tax NO.:

    913706006134231455
  • Registered Funds:

    50 million yuan
  • Website:

  • Email:

Related Drugs
Urinary gonadotropin for injection
This product is a sterile product extracted from the urine of menopausal women and refined by adding appropriate excipients and freeze-drying. It contains two biologically active ingredients, follicle-stimulating hormone and luteinizing hormone, and the ratio of the two is about 1.
Name Description Content CAS NO. Registered Holders
Glycoprotein gonadotropin

It has the function of follicle-stimulating hormone (FSH), promoting the development and maturation of ovarian follicles and the production and secretion of steroid hormones in the testicles. It can make the endometrium of women proliferate and promote the development of seminiferous tubules, spermatogenic cell division and sperm maturation in men.

More

It has the function of follicle-stimulating hormone (FSH), promoting the development and maturation of ovarian follicles and the production and secretion of steroid hormones in the testicles. It can make the endometrium of women proliferate and promote the development of seminiferous tubules, spermatogenic cell division and sperm maturation in men.

0
Nadroparin Calcium for Injection
Name Description Content CAS NO. Registered Holders
HEPARIN CALCIUM

Not clearly described

More

Not clearly described

37270-89-6 23
Nadroparin Calcium for Injection
Name Description Content CAS NO. Registered Holders
HEPARIN CALCIUM

37270-89-6 23
Hydrocortisone Sodium Succinate for Injection
The main ingredient of this product: hydrocortisone sodium succinate.
Name Description Content CAS NO. Registered Holders
Hydrocortisone sodium succinate

It has multiple pharmacological effects such as anti-inflammatory, anti-allergic and immunosuppressive. 1 Anti-inflammatory effect: Glucocorticoids reduce and prevent tissue response to inflammation, thereby reducing the manifestation of inflammation. 2 Immunosuppressive effect: prevent or inhibit cell-mediated immune response, delayed allergic reaction, and reduce the expansion of primary immune response. 3 Anti-toxic and anti-shock effect: Glucocorticoids can counteract the stimulation of bacterial endotoxins on the body, reduce cell damage, and play a role in protecting the body.

More

It has multiple pharmacological effects such as anti-inflammatory, anti-allergic and immunosuppressive. 1 Anti-inflammatory effect: Glucocorticoids reduce and prevent tissue response to inflammation, thereby reducing the manifestation of inflammation. 2 Immunosuppressive effect: prevent or inhibit cell-mediated immune response, delayed allergic reaction, and reduce the expansion of primary immune response. 3 Anti-toxic and anti-shock effect: Glucocorticoids can counteract the stimulation of bacterial endotoxins on the body, reduce cell damage, and play a role in protecting the body.

125-04-2 10
Hydrocortisone Sodium Succinate for Injection
The main ingredient of this product: hydrocortisone sodium succinate.
Name Description Content CAS NO. Registered Holders
Hydrocortisone sodium succinate

It has multiple pharmacological effects such as anti-inflammatory, anti-allergic and immunosuppressive, including reducing and preventing tissue response to inflammation, preventing or inhibiting cell-mediated immune response, delayed allergic reaction, and reducing the expansion of primary immune response, as well as counteracting the stimulation of bacterial endotoxins on the body, reducing cell damage and playing a role in protecting the body.

More

It has multiple pharmacological effects such as anti-inflammatory, anti-allergic and immunosuppressive, including reducing and preventing tissue response to inflammation, preventing or inhibiting cell-mediated immune response, delayed allergic reaction, and reducing the expansion of primary immune response, as well as counteracting the stimulation of bacterial endotoxins on the body, reducing cell damage and playing a role in protecting the body.

125-04-2 10
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.